Philip J. Rosenfeld

Ranibizumab for Neovascular Age-Related Macular Degeneration

Philip J. Rosenfeld, David M. Brown, Jeffrey S. Heier et al. · New England Journal of Medicine · 2006 · 5.8K citations · Full text

Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies

Steven D. Schwartz, Carl D. Regillo, Byron L. Lam et al. · The Lancet · 2014 · 1.3K citations

Macular Dystrophy, Developmental Biology, Retina +10

A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication

Katherine A. Jones, James T. Kadonaga, Philip J. Rosenfeld et al. · Cell · 1987 · 1.1K citations

Chromatin, Transcriptional Regulation, Eukaryotic Transcription +13

An Optical Coherence Tomography-Guided, Variable Dosing Regimen with Intravitreal Ranibizumab (Lucentis) for Neovascular Age-related Macular Degeneration

Anne E. Fung, Geeta A. Lalwani, Philip J. Rosenfeld et al. · American Journal of Ophthalmology · 2007 · 966 citations

Ocular Disease, Vitreous Body, Optical Coherence Tomography-guided +6

Optical Coherence Tomography Findings After an Intravitreal Injection of Bevacizumab (Avastin®) for Neovascular Age-Related Macular Degeneration

Philip J. Rosenfeld, Andrew A. Moshfeghi, Carmen A. Puliafito · Ophthalmic surgery, lasers & imaging retina · 2005 · 902 citations